NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has partnered with Sciencewerke for the international distribution of its clinical next-generation sequencing tests.

Sciencewerke is a sales, marketing, and distribution company. It is headquartered in Singapore and has offices in Malaysia and Indonesia. It will distribute Courtagen's NGS-based tests for neurological and metabolic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.